Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22,925	21,573	20,525	33,154	44,361	26,346
Market Cap Growth	-19.74%	5.11%	-38.09%	-25.26%	68.38%	105.51%
Enterprise Value	24,526	23,045	20,899	31,905	43,858	26,465
Last Close Price	54.78	51.32	48.98	78.91	105.81	64.63
PE Ratio	50.30	61.99	141.14	86.55	73.16	114.14
Forward PE	31.85	42.25	65.91	49.20	99.01	94.53
PS Ratio	8.35	8.78	8.64	14.76	23.72	16.95
PB Ratio	4.07	4.03	4.14	7.08	10.70	10.67
P/TBV Ratio	5.59	7.45	6.38	11.18	14.20	17.03
P/FCF Ratio	73.78	-	-	-	-	-
P/OCF Ratio	16.23	23.60	66.91	62.96	68.67	47.46
PEG Ratio	3.08	3.08	3.08	3.08	3.08	3.08
EV/Sales Ratio	8.90	9.38	8.79	14.21	23.45	17.03
EV/EBITDA Ratio	32.75	39.86	46.08	61.61	76.95	58.22
EV/EBIT Ratio	60.32	82.34	100.98	91.48	105.74	84.89
EV/FCF Ratio	78.94	-	-	-	-	-
Debt / Equity Ratio	0.41	0.45	0.21	0.00	0.00	0.26
Debt / EBITDA Ratio	3.11	4.17	2.27	0.02	0.00	1.42
Debt / FCF Ratio	7.50	-	-	-	-	-
Asset Turnover	0.30	0.29	0.34	0.39	0.40	0.41
Inventory Turnover	1.56	1.16	0.81	0.72	0.86	0.75
Quick Ratio	0.59	0.58	0.59	1.36	3.64	0.82
Current Ratio	0.86	0.85	0.82	1.86	4.22	1.12
Return on Equity (ROE)	8.04%	6.47%	2.59%	8.60%	18.18%	9.67%
Return on Assets (ROA)	2.79%	2.05%	1.82%	3.79%	5.54%	5.13%
Return on Capital (ROIC)	3.29%	2.54%	2.42%	4.93%	7.14%	6.54%
Return on Capital Employed (ROCE)	5.40%	3.80%	3.60%	6.50%	8.70%	9.10%
Earnings Yield	2.00%	1.61%	0.71%	1.16%	1.37%	0.88%
FCF Yield	1.36%	-0.84%	-3.43%	-0.70%	-0.09%	-0.25%
Dividend Yield	0.31%	0.33%	0.14%	0.32%	0.29%	0.29%
Payout Ratio	31.34%	31.69%	95.94%	35.93%	19.74%	41.05%
Buyback Yield / Dilution	-0.53%	-1.10%	0.02%	-2.32%	-1.09%	-1.35%
Total Shareholder Return	-0.22%	-0.77%	0.16%	-2.00%	-0.80%	-1.06%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.